MedTrace Logo

Effects of Temazepam in Patients With Chronic Pulmonary Obstructive Disease

NCT00245661 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2007-11-02

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of temazepam during sleep and in daytime on dyspnea, gas exchange and sleep quality in patients with chronic obstructive pulmonary disease.

The study hypothesis is that temazepam does not produce any adverse respiratory effects during sleep in patients with COPD. In contrast, it may result in an beneficiary effect because it positively affects the sleep quality and sleep structure which may result in more alertness and less daytime sleepiness and less dyspnea during the day.

Conditions

Interventions

DRUG

Temazepam

Sponsors & Collaborators

  • Rijnstate Hospital

    lead OTHER

Principal Investigators

  • Gerben Stege, MD · Rijnstate Hospital

  • Peter J de Bruijn, MD · Rijnstate Hospital

  • Richard PN Dekhuijzen, Prof. PhD MD · UMC St. Radboud

  • Frank JJ van den Elshout, PhD MD · Rijnstate Hospital

  • Yvonne F Heijdra, PhD MD · UMC St. Radboud

  • Marjo JT van de Ven, PhD MD · Rijnstate Hospital

  • Petra JE Vos, PhD MD · Rijnstate Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Completion
2007-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00245661 on ClinicalTrials.gov